“…42 The higher expression of GOLM1 is associated with decreased survival in lung cancer, melanoma, colorectal cancer, uveal melanoma and HCC. 29,40,43,44 As recently reviewed elsewhere, 9 GOLM1 expression can be increased by multiple extracellular factors in the tumor microenvironment, including hypoxia, 22 various miRNAs, [45][46][47] and the cytokines IL-1b, 48 IL-6 and Oncostatin M. 49 However, the upregulation of GOLM1 is not a universal phenomenon in cancer, because lower levels of GOLM1 have been reported in colon cancer. 23 Likely as a consequence of aberrantly high expression of GOLM1, cancer cells can secrete high levels of sGOLM1, as reported for HCC 18,50 and prostate cancer.…”